Mannatech, Incorporated (NASDAQ:MTEX) Short Interest Update

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 4,300 shares, a growth of 65.4% from the November 15th total of 2,600 shares. Based on an average daily volume of 4,700 shares, the short-interest ratio is presently 0.9 days. Currently, 0.4% of the shares of the stock are short sold.

Mannatech Trading Down 3.5 %

Shares of NASDAQ MTEX traded down $0.43 during trading on Thursday, hitting $11.78. 2,116 shares of the company were exchanged, compared to its average volume of 3,135. The company has a fifty day moving average price of $8.49 and a 200-day moving average price of $7.77. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The firm has a market capitalization of $22.15 million, a PE ratio of -14.55 and a beta of 1.18. Mannatech has a 12-month low of $6.75 and a 12-month high of $13.00.

Mannatech (NASDAQ:MTEXGet Free Report) last posted its earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.

Analyst Ratings Changes

Separately, StockNews.com began coverage on Mannatech in a report on Thursday. They issued a “buy” rating for the company.

Get Our Latest Stock Report on MTEX

About Mannatech

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Further Reading

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.